AMEX · JIII
Financial Services · Asset Management
$48.88
Down-$0.19 (-0.38%)
Updated Sep 23, 2026, 3:16 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
JIII closed at $48.88 after 20 trading sessions, down 1.81% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $48.96 | $48.9762 | $48.79 | $48.88 | 165.52K |
| Sep 21, 2026 | $48.915 | $49.18 | $48.60 | $48.95 | 51.32K |
| Sep 18, 2026 | $48.83 | $48.9209 | $48.73 | $48.8204 | 43.84K |
| Sep 17, 2026 | $48.862 | $48.93 | $48.77 | $48.92 | 46.6K |
| Sep 16, 2026 | $48.74 | $48.90 | $48.64 | $48.6962 | 24.6K |
| Sep 15, 2026 | $48.40 | $48.77 | $48.36 | $48.716 | 409.53K |
| Sep 14, 2026 | $48.49 | $48.52 | $48.355 | $48.435 | 27.52K |
| Sep 11, 2026 | $48.74 | $48.7466 | $48.40 | $48.535 | 43.42K |
| Sep 10, 2026 | $48.77 | $48.78 | $48.565 | $48.65 | 19.71K |
| Sep 9, 2026 | $49.03 | $49.0491 | $48.93 | $48.93 | 17.1K |
| Sep 8, 2026 | $49.14 | $49.14 | $49.0101 | $49.04 | 20.6K |
| Sep 4, 2026 | $49.19 | $49.19 | $49.03 | $49.10 | 22.15K |
| Sep 3, 2026 | $49.22 | $49.22 | $49.03 | $49.08 | 31.62K |
| Sep 2, 2026 | $49.15 | $49.16 | $49.00 | $49.04 | 60.15K |
| Sep 1, 2026 | $49.26 | $49.26 | $49.01 | $49.01 | 17.64K |
| Aug 31, 2026 | $49.40 | $49.40 | $49.23 | $49.23 | 30.27K |
| Aug 28, 2026 | $49.70 | $49.73 | $49.52 | $49.54 | 20.61K |
| Aug 27, 2026 | $49.79 | $49.95 | $49.66 | $49.66 | 95.91K |
| Aug 26, 2026 | $49.70 | $49.81 | $49.695 | $49.72 | 5.68K |
| Aug 25, 2026 | $49.76 | $49.84 | $49.72 | $49.78 | 35.05K |
The latest Smart Investors Daily articles mentioning JIII.
JIII research
Company profile and research snapshot.
The fund pursues its investment objective by primarily investing, under normal circumstances, in a multi-sector portfolio of U.S. and non-U.S. debt securities of varying maturities that portfolio management believes have high income potential relative to other fixed-income instruments available at a given point in time. The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Jul 16, 2026
Explore JIII active bond ETF: diversified corporates, Treasuries, MBS & CLOs with 6.4% yield, balanced risk and low volatilityâlearn more now.
GlobeNewswire Inc. · Sep 10, 2025
CAMP4 Therapeutics secured a private placement of up to $100 million to advance its first-in-class treatment for SYNGAP1-related disorders, with $50 million in upfront proceeds and potential additional funding contingent on clinical milestones.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning JIII.
No results
No recent SID articles mention JIII.
